More about

Hiv Infection

News
June 09, 2018
2 min read
Save

PRO 140 on track to be part of combination MDR HIV treatment

ATLANTA — Positive results presented here support the continued development of PRO 140 — CytoDyn’s investigational humanized monoclonal antibody for the treatment of patients with HIV who are failing their current ART regimens.

News
August 16, 2016
3 min watch
Save

VIDEO: Factors underlying HIV persistence impact search for cure

VIDEO: Factors underlying HIV persistence impact search for cure

There are several mechanisms that contribute to HIV persistence, all of which may influence the ability to develop a cure, according to Jonathan Z. Li, MD, MMSc, assistant professor of medicine at Harvard Medical School and Brigham and Women’s Hospital and member of the AIDS Clinical Trials Group at Brigham and Women’s Hospital.

News
July 26, 2016
2 min read
Save

Guest Commentary: Limited Medicaid expansion leaves many blacks, women with HIV uninsured

Guest Commentary: Limited Medicaid expansion leaves many blacks, women with HIV uninsured

In this guest commentary, Adaora Adimora, MD, MPH, FIDSA, professor of medicine and epidemiology at the University of North Carolina, Chapel Hill, and immediate past president of the HIV Medicine Association, discusses the role of the Affordable Care Act in increasing health insurance coverage among people with HIV and the gaps in coverage that remain, particularly among individuals of low socioeconomic status and blacks.

News
June 10, 2016
3 min read
Save

US observes 35th anniversary of first reported cases of AIDS

US observes 35th anniversary of first reported cases of AIDS

On June 5, 1981, the CDC published an MMWR on five cases of Pneumocystis carinii pneumonia among previously healthy young men in Los Angeles, a report would later be recognized as the first cases of AIDS in the U.S. June 5, 2016 marked the 35th anniversary of this report.

News
December 16, 2015
6 min watch
Save

VIDEO: Raphael J. Landovitz, MD, reviews barriers, solutions to use of PrEP in women

VIDEO: Raphael J. Landovitz, MD, reviews barriers, solutions to use of PrEP in women

The use of pre-exposure prophylaxis, or PrEP, in women is “a little bit more complicated” compared with men, according to Raphael J. Landovitz, MD, of the UCLA Center for Clinical AIDS Research and the David Geffen School of Medicine at UCLA.

News
December 14, 2015
2 min read
Save

Sexual disclosure laws require reconsideration for teens with HIV

ATLANTA — Troubled adolescents with HIV infection often experience social barriers that prevent or discourage disclosure of their status to sexual partners that can lead to prosecution. Barriers among this at-risk demographic highlight the need for a review of zero-tolerance mandatory disclosure laws, according to a study presented at the CDC’s National HIV Prevention Conference.

News
December 11, 2015
1 min read
Save

Opt-out testing at children’s hospitals increases HIV testing rate

ATLANTA — Hospitalwide opt-out testing was successful at increasing the HIV testing rate among children aged 13 years and older at two U.S. children’s hospitals, according to data presented at the CDC’s National HIV Prevention Conference.

News
December 10, 2015
1 min read
Save

MSM who exchange sex for money often unaware of HIV infection

ATLANTA — Men who have sex with men who reported exchanging sex for money are more likely to be unaware of their HIV infection, according to data reported here at the CDC’s National HIV Prevention Conference.

News
December 09, 2015
2 min read
Save

Prompt linkage to care reduces HIV progression, time to viral suppression

Prompt linkage to care reduces HIV progression, time to viral suppression

ATLANTA — HIV patients linked to care within 1 month achieved viral suppression quicker than those linked to care within 3 months, according to research data presented at the CDC’s National HIV Prevention Conference.

News
December 07, 2015
1 min read
Save

PCPs frequently unaware of PrEP

PCPs frequently unaware of PrEP

ATLANTA — Primary care clinicians frequently reported low awareness of pre-exposure prophylaxis, but once informed they often were interested in prescribing the treatment and pursuing education concerning its appropriate use, according to survey data presented at the CDC’s National HIV Prevention Conference.

View more